Newsletter Subject

OK to Perform 'Female Circumcision'? MD/JD Weighs In; Rampant Rash; Caution on Inhibitor

From

medpagetoday.com

Email Address

daily.headlines@broadcaster3.medpagetoday.com

Sent On

Sat, Mar 13, 2021 04:01 PM

Email Preheader Text

Time to test those Dx skills On the Case Intriguing, curious, and mysterious case studies Saturday,

Time to test those Dx skills [MEDPAGE TODAY]( On the Case Intriguing, curious, and mysterious case studies Saturday, March 13, 2021 Got an interesting case of your own? Send it over to editorial@medpagetoday.com for consideration! [Word of Caution on Angiogenesis Inhibitor for Liver Cancer]( A 66-year-old man presents to an emergency department in New York City with confusion and progressively worsening altered mental status. Two years previously he was diagnosed with stage 3b hepatocellular carcinoma (HCC), and his comorbidities include liver cirrhosis, chronic hepatitis C (Child-Turcotte-Pugh B), and hypothyroidism. [Solve Case]( How about another? [Rampant Rash]( A mother brought her 3-year-old to the pediatrician concerned about a rash that developed a few days into what had seemed like a normal cold. The little girl had started with a runny nose and slight fever, and had been acting more tired than usual. After a few days her cheeks became bright red and a blanching macular rash slowly spread from her extremities to her trunk. [Make the Diagnosis]( Ethics Consult [OK to Perform 'Female Circumcision'? MD/JD Weighs In]( Last week, you voted on the ethics of performing genital cutting on a young woman. See the results and an expert's discussion. [Make the Call]( [A Property of Everyday Health group]( © 2021 MedPage Today, LLC. MedPage Today is among the federally registered trademarks of MedPage Today, LLC, and may not be used by third parties without explicit permission. You have received this email because you have registered to receive emails at www.medpagetoday.com, with the email address: {EMAIL} [Manage Email Preferences]( | [Unsubscribe](lst=NL_Gen_Int_On_The_Case?xid=nl_mpt_Onthecase2021-03-13&eun=g1020308d0r) | [Terms of Use]( | [Privacy Policy]( Technical Questions: feedback@medpagetoday.com 345 Hudson Street 16th Floor New York, NY 10014

Marketing emails from medpagetoday.com

View More
Sent On

08/12/2024

Sent On

08/11/2024

Sent On

07/11/2024

Sent On

07/11/2024

Sent On

06/11/2024

Sent On

04/11/2024

Email Content Statistics

Subscribe Now

Subject Line Length

Data shows that subject lines with 6 to 10 words generated 21 percent higher open rate.

Subscribe Now

Average in this category

Subscribe Now

Number of Words

The more words in the content, the more time the user will need to spend reading. Get straight to the point with catchy short phrases and interesting photos and graphics.

Subscribe Now

Average in this category

Subscribe Now

Number of Images

More images or large images might cause the email to load slower. Aim for a balance of words and images.

Subscribe Now

Average in this category

Subscribe Now

Time to Read

Longer reading time requires more attention and patience from users. Aim for short phrases and catchy keywords.

Subscribe Now

Average in this category

Subscribe Now

Predicted open rate

Subscribe Now

Spam Score

Spam score is determined by a large number of checks performed on the content of the email. For the best delivery results, it is advised to lower your spam score as much as possible.

Subscribe Now

Flesch reading score

Flesch reading score measures how complex a text is. The lower the score, the more difficult the text is to read. The Flesch readability score uses the average length of your sentences (measured by the number of words) and the average number of syllables per word in an equation to calculate the reading ease. Text with a very high Flesch reading ease score (about 100) is straightforward and easy to read, with short sentences and no words of more than two syllables. Usually, a reading ease score of 60-70 is considered acceptable/normal for web copy.

Subscribe Now

Technologies

What powers this email? Every email we receive is parsed to determine the sending ESP and any additional email technologies used.

Subscribe Now

Email Size (not include images)

Font Used

No. Font Name
Subscribe Now

Copyright © 2019–2025 SimilarMail.